OBJECTIVE: To investigate the effects of the neurotrophin-3 (NTF3) gene on the survival and differentiation of neural stem cells (NSCs) in vitro and in vivo. METHODS: The NTF3 gene was isolated from rats, amplified by polymerase chain reaction (PCR) and subcloned into the lentiviral vector pWPXL-MOD to construct a lentiviral expression vector pWPXL-MOD-NTF3. Reverse transcription-PCR and Western blotting were used to analyse NTF3 mRNA and protein levels, respectively. Adult rats with sectioned tibial nerves received implants of NSCs transfected with either pWPXL-MOD-NTF3 (n = 30) or an empty expression vector (n = 30). In vitro and in vivo cell differentiation and survival were determined by fluorescence immunohistochemistry. RESULTS: Expression of NTF3 significantly increased the differentiation of NSCs into cholinergic neurons both in vitro and in vivo. NTF3expressing NSCs implanted into the tibial nerve also survived longer than cells without NTF3 gene modification. CONCLUSIONS: The NTF3 gene promoted differentiation of NSCs into cholinergic neurons and enhanced neuronal cell survival. These findings may have clinical implications for cell transplantation therapy in patients with nerve injury.
Introduction
Neural stem cells (NSCs) are multipotent progenitor cells with self-renewal properties. A single NSC is capable of differentiating into various central nervous system (CNS) cells including neurons, astrocytes and oligodendrocytes 1 and, as such, NSC transplantation may have a clinical application in cases of denervated musculoskeletal atrophy following peripheral nerve injury. 2 Neural stem cells from adult or embryonic S Lin, Y Wang, C Zhang et al. Effects of NTF3 on neural stem cell differentiation brains, 1 embryonic stem cells 3 and cells originating from the bone marrow have been used for the reproduction of CNS cells. 4 Understanding the mechanisms of neural differentiation and survival is important to the development of feasible neuronal transplantation strategies that delay denervated musculoskeletal atrophy. Published studies have demonstrated that cytokines, growth factors and drugs can all influence the survival or differentiation of NSCs. 5 -8 The neurotrophins are a family of proteins that regulate the survival, differentiation and maintenance of neurons and some non-neuronal cells. 9 Neurotrophin-3 (NTF3) has a pivotal role within the nervous system, promoting neuronal survival, differentiation and migration of neuronal cells. 10 -12 The present study examined the effects of NTF3 expression on the differentiation of NSCs from rat embryonic spinal cord and the differentiation and survival of implanted NSCs in a rat model of tibial nerve transfection.
Materials and methods PREPARATION AND CULTURE OF NSCs FROM RAT EMBRYO SPINAL CORD
Neural stem cells were obtained from the spinal cord of P14 Sprague-Dawley rat embryos (Experimental Animals Centre, Chinese Academy of Science, Shanghai, China) as described previously with slight modification. 13 Cells (1 × 10 6 ml) were cultured in basic culture medium comprising 1:1 Dulbecco's Modified Eagle Medium and F-12 nutrient (DMEM/F-12; Gibco BRL/Life Technologies, Gaithersburg, MD, USA) that included N2 supplement (1:100 dilution) and B-27 supplement (1:50 dilution) (both also from Gibco BRL/Life Technologies) and 20 ng/ml epidermal growth factor and 20 ng/ml basic fibroblast growth factor (both from R&D Systems, Minneapolis, MN, USA) for 5 -7 days. A half-volume of medium was replaced with fresh medium every 3 -4 days.
All experiments involving animals and animal tissues were approved by the Committee Review of Huashan Hospital, Shanghai, China and were conducted according to the China Public Health Service Policy on Humane Care and Use of Laboratory Animals (protocol ID: SYXK-hu-2009-0082).
NTF3 GENE CLONING AND CONSTRUCTION OF LENTIVIRAL EXPRESSION VECTOR
Rat NTF-3 cDNA (RZPD German Resource Centre for Genome Research, Berlin, Germany) was amplified by polymerase chain reaction (PCR) using the following primers: forward, GGCACTAGTTCATGTTC TTCCGATTTTTC; reverse, GGGACGCGTCAA GGTGATGTCCATCTTGTTTT. The PCR was carried out using the Axygen Taq polymerase kit and Axygen PCR clean-up kit (Axygen Biosciences, Hangzhou, China) and a thermal cycler (Applied Biosystems, Foster City, CA, USA). The cycling programme involved preliminary denaturation at 94°C for 5 min, followed by 35 cycles of denaturation at 94°C for 30 s, annealing at 60°C for 30 s and elongation at 72°C for 75 s, followed by a final elongation step at 72°C for 10 min. The PCR products were analysed by 1.5% agarose gel electrophoresis; a 777 base-pair nucleotide fragment indicated amplification of the full-length NTF3 gene ( Fig. 1 ). Sequencing of the PCR product was carried out by Shanghai Telebio Biomedical Co. (Shanghai, China) and confirmed the identity of the cloned fragment as the NTF3 gene. To construct the vector pWPXL-MOD-NTF3, the PCR product was digested with S Lin, Y Wang, C Zhang et al.
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Hind III at 37°C for 4 h and inserted into the lentiviral expression vector pWPXL-MOD (Shanghai Telebio Biomedical Co.), according to the manufacturer's instructions, at the green fluorescent protein (GFP) site.
TRANSFECTION OF NSCs WITH THE NTF3 GENE
To generate NTF3 positive NSC clones and negative control NSC clones, cultured NSCs (5 × 10 6 cells/transfection) were transfected for 5 days at 37°C with either the pWPXL-MOD-NTF3 vector or an empty expression vector pWPXL-MOD, at 10 8 TU/ml, using Lipofectamine™ (Gibco BRL/Life Technologies), according to the manufacturer's instructions, in the basic culture medium referred to above. Stably transfected positive clones expressing the NTF3 gene were screened by fluorescence analysis for GFP and maintained in culture at 37°C in 5% carbon dioxide. Transfected cells were analysed for NTF3 mRNA and protein using reverse transcription-PCR (RT-PCR) and Western blot analyses as described below.
RT-PCR ANALYSIS OF NTF3 MRNA LEVELS
To verify NTF3 expression by NTF3 positive NSCs, stably transfected cells (1 × 10 6 cells/ml), prepared as described above, were washed in 0.1 mM phosphate-buffered saline (PBS, pH 7.4) and total RNA was extracted with the RNeasy RNA extraction kit (Axygen Biosciences, Union City, CA, USA) according to the manufacturer's instructions.
Total RNA (2 µg) was reverse-transcribed using RNase reverse transcriptase and 0.5 µg/µl oligo(dT)18 primer, 20 U/µl RNA inhibitors, 10 mmol/l dNTP mix, and 10 U/µl Moloney Murine Leukaemia Virus (M-MLV) reverse transcriptase (all from Gibco BRL/Life Technologies) for 1 h at 42°C. The synthesized cDNA was treated with RNase H (Thermo Fisher Scientific, Rockford, IL, USA) and amplified using an Axygen Taq polymerase kit, an Axygen PCR clean-up kit, an Applied Biosystems 2720 thermal cycler and the primer sequences for the NTF3 gene described above. The PCR conditions were optimized and the linear amplification range was determined for each primer by varying the annealing temperature and cycle number. The cycling programme involved preliminary denaturation at 94°C for 5 min, followed by 30 cycles of denaturation at 94°C for 45 s, annealing at 55°C for 45 s and elongation at 72°C for 75 s, followed by a final elongation step at 72°C for 10 min. After amplification, the PCR products underwent electrophoresis on a 1.5% agarose gel and were visualized by ethidium bromide staining. The density of each band was normalized against that of β-actin; samples lacking the amplified β-actin product were not processed further. 
WESTERN BLOT ANALYSIS OF NTF3 PROTEIN
To verify NTF3 expression by NTF3 positive NSCs, Western blot analysis was carried out, as described previously, 14 using stably transfected cells prepared as described above. Briefly, the day before harvesting, 5 × 10 6 cells/ml grown on 24-well plates (BD Falcon™; BD Biosciences, San Jose, CA, USA) were washed with Hank's balanced salt solution (HBSS) and replenished with 500 µl of serum-free DMEM in each well. The cells were cultured for an additional 24 h before the medium was collected and mixed with an equal volume of sample buffer (125 mM Tris-HCl, 4% sodium dodecyl sulphate [SDS], 20% glycerol and 10% 2-mercaptoethanol) at pH 6.8. The cells were gently scraped off the plates and homogenized with a Teflonglass homogenizer in 5 µl of homogenization buffer (50 mM Tris-HCl [pH 7.5], 2 mM ethylenediaminetetra-acetic acid, 1 mM phenylmethylsulphonyl fluoride, 25 mM leupeptin and 1% aprotinin). The homogenate was centrifuged at 13 000 g for 15 min at 4°C and the resulting supernatant was mixed with an equal amount of sample buffer. The protein content of each sample was assessed by the Bradford assay and equal amounts of protein were separated by 10% SDS-polyacrylamide gel electrophoresis and transferred onto polyvinylidene difluoride membranes (Millipore, Billerica, MA, USA).
The membranes were blocked for 1 h at 4°C with 5% nonfat dry milk in Tris-buffered saline (150 mM saline and 50 mM Tris-HCl), pH 7.6, containing 0.1% Tween 20 (TBST) followed by overnight incubation at 4°C with a 1:2000 dilution of polyclonal rabbit anti-NTF3 and antiglyceraldehyde 3phosphate dehydrogenase antibodies (both from Chemicon International, Temecula, CA, USA) followed by incubation with horseradish peroxidase-conjugated goat antirabbit immunoglobulin G (IgG; 1:4000 dilution; Sigma-Aldrich, St Louis, MO, USA) for 1 h at room temperature. Between each stage, the membranes were washed three times with TBST. Immunoreactivity was visualized by enhanced chemiluminescence reagents (Thermo Fisher Scientific) according to the manufacturer's instructions.
IN VITRO DIFFERENTIATION OF NTF3 POSITIVE NSCS AND NSC CONTROLS
Tissue culture-treated chamber slides (Nalge Nunc International, Rochester, NY, USA) were coated with 0.01% poly-L-lysine (Sigma-Aldrich) for 60 min at room temperature, washed with deionized water and allowed to dry. The NTF3 positive NSCs and NSC control cells (3000 cells/cm 2 ) were seeded in basic culture medium into the chamber of the slide and maintained at 37°C at 95% humidity with 5% carbon dioxide to promote adherence. After 2 h, basic medium was replaced with a differentiation medium consisting of DMEM/F-12 plus 20% fetal bovine serum. The cells were then cultured for 7 days after which the culture medium was removed and the cells were rinsed three times with 0.1 mM PBS, pH 7.4. The cells were then fixed with 4% paraformaldehyde for 30 min and immersed in 0.1 mM PBS, pH 7.4, for approximately 10 min before exposure to 0.01% Triton X-100 at room temperature for a further 10 min. Fluorescence immunocytochemistry was performed to evaluate specific differentiation markers.
After incubation with 10% normal goat serum (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at room temperature for 30 min to block nonspecific immune reactions, the cells were incubated with a 1: 
TIBIAL NERVE SURGERY AND NSC TRANSPLANTATION
Permanent and complete denervation of the lower leg 15, 16 was surgically induced in 60 adult male Sprague-Dawley rats (weight range 120 -150 g; mean ± SD age 3.0 ± 0.2 months). The rats were housed under a 12-h light/12-h dark cycle, maintained at a constant temperature, and provided with food and water ad libitum both pre-and postsurgery. Prior to surgery, the rats were randomly assigned, using a computergenerated randomization schedule, to two treatment groups: implantation with NTF3 positive NSCs (experimental group, n = 30) and implantation with NSC control cells (control group, n = 30). They were anaesthetized with 50 mg/kg sodium pentobarbital via intraperitoneal (i.p.) injection. Heart rate and respiratory rhythm were monitored during anaesthesia. After skin incision, the sciatic, tibial and peroneal nerves were exposed using a muscle splitting incision. With the aid of an operation microscope (SM-2000J; Shanghai Eder, Shanghai, China), the right tibial nerve was severed 1 cm above the gastrocnemius muscle. The tibial nerve was then tightly ligated with surgical silk in two locations and cut between the sutures before a 0.4 cm section was removed. Both proximal and distal nerve stumps were anchored in the surrounding tissue as far apart as possible. Penicillin powder was put into the wound to keep the animals infection free.
Cell transplantation was carried out 7 days after severing the tibial nerve. On the day of surgery, NSCs that were 90% confluent were washed three times with HBSS, trypsinized, gently titrated, counted, washed, centrifuged at 302 g for 5 min and resuspended in basic growth medium. Cell viability, as shown by trypan blue staining (Sigma-Aldrich), was 80 -90% prior to surgery. The cells were maintained on ice during surgery. Under anaesthesia (50 mg/kg sodium pentobarbital i.p.), surgicallyprepared rats received a 20 µl injection, using a microsyringe, of NTF3 positive NSCs or NSC controls (10 5 cells/µl) over 10 min into the tibial nerve proximal to the nerve branch of the gastrocnemius muscle. The needle was left in place for 15 min after injection before withdrawal with the aid of an operation microscope. Ligatures were placed proximal to the injection site to secure the implanted cells further and to prevent infiltration by endogenous nerves. The wound was subsequently closed in layers using 5-0 silk sutures. Ten animals each in the experimental and control groups were sacrificed at week 1 (subgroup 1), week 4 (subgroup 2) and week 12 (subgroup 3) after surgery and tissue samples of tibial nerve were removed as detailed below. 
TIBIAL NERVE TISSUE PREPARATION

IMMUNOHISTOCHEMISTRY
Tissue sections of tibial nerve from animals in subgroup 1 were incubated with antinestin antibody (1:200 dilution; Sigma-Aldrich) and sections from animals in subgroups 2 and 3 were incubated with anti-ChAT antibody (1:200 dilution; Chemicon International) for 12 h at 4°C. The sections were then incubated with Cy3-conjugated goat antimouse IgG (1:100 dilution; Sigma-Aldrich) for 2 h at room temperature. At each stage, the slides were washed three times using 0.1 mM PBS, pH 7.4. To avoid nonspecific immunostaining by antimouse secondary reagents, negative control staining was performed using mouse IgG. Quantification of nestin and ChAT immunopositive cells was performed using the Leica QWin Standard V3.1 system.
STATISTICAL ANALYSES
The mean ± SE of the data were calculated. Comparisons between the experimental and control groups were performed using oneway analysis of variance with Bonferroni's post hoc test at each time point postsurgery. A P-value < 0.05 was considered to be statistically significant.
Results
Both NTF3 mRNA and protein were increased in NTF3 positive NSCs compared with NSC control cells ( Fig. 2A and 2B , respectively). 
Effects of NTF3 on neural stem cell differentiation
Following cultivation in differentiation medium for 7 days, NTF3 positive NSCs differentiated into ChAT-immunopositive cells (Fig. 3A) and GFAP-immunopositive cells (Fig. 3B) . Differentiation into ChAT-or GFAP-positive cells was not detected in NSC control cells (data not shown).
Analysis of tibial nerve tissue from rats that underwent tibial nerve sectioning followed by transplantation of NTF3 positive NSCs or NSC control cells showed that NSC grafts were able to survive in the grafted region after implantation. At 1 week postimplantation, nestin-positive cells were detected at the injection site of the experimental group (Fig. 4A ) and the control group (data not shown). At 4 weeks after implantation, the proportion of ChATimmunopositive cells was significantly higher in the experimental group compared with the control group (P < 0.01; Fig 4B, 4C) . At 12 weeks postimplantation, ChATimmunopositive cells could only be detected in the experimental group (Fig. 4D) ; control group data not shown.
Discussion
Cell-based therapy using multipotent stem cells may be of clinical benefit in delaying denervated musculoskeletal atrophy. 17, 18 NSCs are easily isolated and can be used for autologous transplantation thereby avoiding detrimental immune reactions. 19 -21 These cells are able to differentiate into neuronal and glial cells but it is difficult to induce the differentiation of NSCs into any particular type of cell under experimental conditions. Growth factors have a critical role in neuronal cell development and studies have reported the use of genetically-modified NSCs to secrete nerve growth factor (NGF) or brain-derived neurotrophic factor in an attempt to influence the differentiation of surrounding cells. 22 It has also been demonstrated in vitro that NCSs infected by lentivirus with human NGF can differentiate into neurons, astrocytes and oligodendrocytes. 23 Neurotrophin-3 plays a key role in brain development, particularly with respect to the differentiation and migration of NSCs, and is also important in neurotransmitter regulation, neural peptide synthesis, neuron morphology and synapse function. 14,24 -26 In addition, NTF3 promotes neuronal survival, peripheral nerve regeneration and the maintenance of neuronal and non-neuronal cells. 27 -30 The present study demonstrated that NTF3 can promote the in vitro differentiation of NSCs into cholinergic neurons. Furthermore, NTF3 enhanced the differentiation of NSCs into cholinergic neurons and extended cell survival in rats that had received a graft of NSCs into surgically-transected peripheral nerve tissue.
The effects of NTF3 gene modification on NSC differentiation and survival in the present study were greater than those previously reported in the literature using alternative methods. 31 -33 In conclusion, the present study showed that cholinergic neurons efficiently developed, both in vitro and in vivo, from NSCs expressing the NTF3 gene, and that grafting of these cells promoted the survival of cholinergic neurons in a rat model of tibial nerve transfection. These findings suggest that the combination of NSCs and the NTF3 gene may represent a novel clinical approach to autologous donor cell transplantation therapy in patients with nerve injury.
